Literature DB >> 33296814

Comparison of main chemical composition of Plantago asiatica L. and P. depressa Willd. seed extracts and their anti-obesity effects in high-fat diet-induced obese mice.

Lan Ji-Ping1, Tong Ren-Chao2, Sun Xiao-Meng1, Zhang Hao-Yue3, Sun Shuai2, Xiong Ai-Zhen2, Wang Zheng-Tao2, Yang Li4.   

Abstract

BACKGROUND: Nowadays, the pharmacological effects of Plantaginis semen was getting more and more attention because of the great effect of treating diuresis, hypertension, hyperlipidemia, and hyperglycemia. According to the Chinese Pharmacopoeia, Plantaginis semen is the seed of Plantago asiatica L. or P. depressa Willd. This was verified by examining chemical composition differences in a preliminary experiment, predicting their differences in pharmacology.
PURPOSE: In this study, we aimed to compared the the differences in main components and anti-obesity effects of Plantago asiatica L. seed extract (PASE) and P. depressa Willd. seed extract (PDSE). STUDY DESIGN AND METHODS: The ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) analysis was used to characterize and compare the differences chemical constituents of PASE and PDSE. The difference therapeutic effects between PASE and PDSE on obesity and associated metabolic disorders was investigated by high-fat (HF) diet induced mice model.
RESULTS: The fingerprint of Plantaginis semen were established by screening and identified 15 main components, including iridoids, phenethanol glycosides, flavonoids, guanidines, and fatty acids. Pentahydroxy flavanone was observed only in PDSE but not in PASE. The quantitative analysis results indicated that the main bioactive components in PASE were geniposidic acid and acteoside; their concentrations were three times higher in PASE than in PDSE. In anti-obesity effects, the result show the levels of fasting blood glucose were improved in both PASE and PDSE when compared with the HF group, while the PASE is show a significant effect then the PDSE group and improved the glucose tolerance but not in PDSE. The results also displayed that the Plantaginis semen did not modify food intake or body weight but decreased abdominal white/brown adipocyte size, serum total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL-c), hepatic TG and TC, fecal TG and TC concentrations when compared with the HF group. Among these indicators, serum TG, liver TG, fecal TC and TG levels were significantly improved in PASE compared with PDSE. The results indicated that PASE treatment more effectively improved lipid and glucose metabolism in HF diet-induced obese mice than did PDSE.
CONCLUSION: As Plantaginis semen sources, P. asiatica L. seeds demonstrated more bioactive components and favorable metabolic disorder treatment outcomes than did P. depressa Willd. seeds.
Copyright © 2020. Published by Elsevier GmbH.

Entities:  

Keywords:  Plantago asiatica L. seed; Plantago depressa Willd. seed; anti-obesity; compositionts

Year:  2020        PMID: 33296814     DOI: 10.1016/j.phymed.2020.153362

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  4 in total

1.  Complete chloroplast genome of Plantago asiatica and its phylogenetic position in Plantaginaceae.

Authors:  Hao Si; Rui Li; Qingde Zhang; Luxian Liu
Journal:  Mitochondrial DNA B Resour       Date:  2022-05-10       Impact factor: 0.610

Review 2.  Plantago media L.-Explored and Potential Applications of an Underutilized Plant.

Authors:  Radu Claudiu Fierascu; Irina Fierascu; Alina Ortan; Alina Paunescu
Journal:  Plants (Basel)       Date:  2021-01-30

3.  Anti-Obesity Effects of a Mixture of Atractylodes macrocephala and Amomum villosum Extracts on 3T3-L1 Adipocytes and High-Fat Diet-Induced Obesity in Mice.

Authors:  Hae-Lim Kim; Sung-Kwon Lee; Da-Eun Min; Bong-Keun Choi; Dong-Ryung Lee
Journal:  Molecules       Date:  2022-01-28       Impact factor: 4.411

4.  Lipidomics study of the therapeutic mechanism of Plantaginis Semen in potassium oxonate-induced hyperuricemia rat.

Authors:  Fei Yang; Wenjun Shi; Liting Wang; Nankun Qin; Chengxiang Wang; Yuying Guo; Guang Xu; Jie Fang; Xue Yu; Qun Ma
Journal:  BMC Complement Med Ther       Date:  2021-06-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.